Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 320.00
Bid: 318.00
Ask: 320.00
Change: 7.00 (2.24%)
Spread: 2.00 (0.629%)
Open: 326.00
High: 326.00
Low: 312.50
Prev. Close: 320.00
VLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Apr 2012 07:00

RNS Number : 1608B
Volex PLC
12 April 2012
 



For immediate release 12 April 2012

VOLEX plc

Trading Update

Volex plc ('Volex' or the 'Group'), the global provider of electrical, digital and optical connections, today releases the following trading update for the three months ended 1 April 2012.

Trading in the final quarter of FY2012 remained resilient despite continuing economic uncertainty. Consumer revenue for the final quarter was in line with the same period last year, while year-on-year revenue growth in the Healthcare sector was again in excess of 20%. Telecoms/Datacoms revenue in the quarter continued to be affected by reduced spend by telecoms operators while trading in the Industrial sector, as predicted, largely recovered from the customer destocking experienced in Q3 FY2012. Consequently overall Q4 FY2012 Group revenue was down slightly on the same period last year, but still up almost 6% for the year as a whole.

The exceptional start-up costs reported in the Interim Management Statement of 13 January 2012 have, as anticipated, been winding down during the course of Q4 due to the on-going operational efficiency and quality improvements. As a result we have exited the year at the targeted yields and the costs for the full year FY2012 are at the lower end of the $5m-$6m range communicated in the IMS. Excluding the impact of these start-up costs, normalised(i) gross margin in Q4 FY2012 was modestly above management's stated objective of exiting the year at around 20%. As a result, full year normalised(i) operating profit will be slightly ahead of market expectations for the twelve months to 1 April 2012.

Despite significantly increased investment in capital expenditures and other areas of the business, cash generation continues to be strong with a net cash position again reported at the year end, ahead of market expectations.

Whilst economic conditions are expected to continue to be challenging in FY2013, the Board is confident that on-going investments, particularly in the areas of sales, operations and technology, will enable the business to deliver continued growth in revenues, margins and profit in line with management's expectations.

Results for the year ended 1 April 2012 will be announced on Tuesday 29 May 2012.

 

(i) Normalised results stated before exceptional start-up costs and share based payments charge

 

- END -

 

 

 

Volex plc

Ray Walsh Group Chief Executive +44 20 3370 8830

Andrew Cherry Group Finance Director +44 20 3370 8830

Buchanan

Charles Ryland / Helen Chan / Louise Hadcocks +44 20 7466 5000

Forward looking statements

Certain statements in this announcement are forward-looking statements which are based on Volex's expectations, intentions and projections regarding its future operating performance and objectives, anticipated events or trends and other matters that are not historical facts. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words as 'anticipates', 'aims', 'could', 'may', 'should', 'expects', 'believes', 'intends', 'plans', 'targets', 'goal' or 'estimates'. By their very nature forward-looking statements are inherently unpredictable, speculative and involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, by way of example only and not limited to, general economic conditions, currency fluctuations, competitive factors, the loss or failure of one or more major customers, changes in raw materials or labour costs, and issues associated with implementing our strategic plan among other risks. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, Volex undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFUFIFFESEDL
Date   Source Headline
18th Apr 20247:00 amRNSFull Year Trading Update
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
26th Jan 20245:13 pmRNSDirector/PDMR Shareholding
16th Jan 202412:33 pmRNSDirector/PDMR Shareholding
10th Jan 20244:45 pmRNSIssue of Equity
22nd Dec 202311:00 amRNSDirector/PDMR Shareholding
7th Dec 20233:42 pmRNSScrip Reference Price
23rd Nov 20237:00 amRNSHalf-year report
8th Nov 20237:15 amRNSAnalyst Briefing & Investor Presentation
24th Oct 20237:00 amRNSUpdate on H1 Trading and Cyber Incident
20th Oct 20237:00 amRNSDirectorate Changes
9th Oct 20237:00 amRNSNotice of Cyber Incident
28th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20237:00 amRNSCompletion of Murat Ticaret Acquisition
30th Aug 20235:00 pmRNSDirector/PDMR Shareholding
21st Aug 20234:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20237:00 amRNSReceipt of Competition Clearance for Murat Ticaret
27th Jul 20236:23 pmRNSResult of AGM
27th Jul 202311:37 amRNSScrip Reference Price
27th Jul 20237:00 amRNSAGM Statement
19th Jul 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20234:40 pmRNSDirector/PDMR Shareholding
28th Jun 20234:59 pmRNSHolding(s) in Company
27th Jun 202310:00 amRNSNotice of AGM and Publication of Annual Report
22nd Jun 20231:00 pmRNSResults of Fundraising
22nd Jun 20237:02 amRNSREX Retail Offer
22nd Jun 20237:01 amRNSAcquisition of Murat Ticaret and Proposed Placing
22nd Jun 20237:00 amRNSPreliminary Group Results FY2023
12th Jun 20237:00 amRNSNotice of Results and Investor Presentation
18th May 20237:00 amRNSChange of Adviser
27th Apr 20237:00 amRNSEV Contract Win
18th Apr 20237:00 amRNSFull Year Trading Update
18th Jan 20237:00 amRNSAnalyst Site Visit
22nd Dec 202210:03 amRNSDirector/PDMR Shareholding
13th Dec 20227:00 amRNSIssue of Equity and Total Voting Rights
24th Nov 20227:00 amRNSScrip Reference Price
9th Nov 20227:00 amRNSHalf-year Report of Volex plc
13th Oct 20227:00 amRNSNotice of Half Year Results
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20223:58 pmRNSDirector / PDMR Dealing
30th Aug 20223:36 pmRNSDirector / PDMR Dealing
19th Aug 20225:32 pmRNSResults of AGM, Issue of Equity and TVR
19th Aug 20227:00 amRNSAGM Statement
29th Jul 20224:00 pmRNSScrip Dividend Scheme and Scrip Reference Price
11th Jul 202210:53 amRNSNotice of AGM and Publication of Annual Report
29th Jun 20225:08 pmRNSDirector/PDMR Shareholding
23rd Jun 20227:00 amRNSPreliminary Group Results FY2022
8th Jun 20227:00 amRNSNotice of Preliminary Results & IMC Presentation
19th May 20227:00 amRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.